Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation
- PMID: 33214651
- PMCID: PMC7675396
- DOI: 10.1038/s41569-020-00469-1
Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation
Abstract
The core pathology of coronavirus disease 2019 (COVID-19) is infection of airway cells by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that results in excessive inflammation and respiratory disease, with cytokine storm and acute respiratory distress syndrome implicated in the most severe cases. Thrombotic complications are a major cause of morbidity and mortality in patients with COVID-19. Patients with pre-existing cardiovascular disease and/or traditional cardiovascular risk factors, including obesity, diabetes mellitus, hypertension and advanced age, are at the highest risk of death from COVID-19. In this Review, we summarize new lines of evidence that point to both platelet and endothelial dysfunction as essential components of COVID-19 pathology and describe the mechanisms that might account for the contribution of cardiovascular risk factors to the most severe outcomes in COVID-19. We highlight the distinct contributions of coagulopathy, thrombocytopathy and endotheliopathy to the pathogenesis of COVID-19 and discuss potential therapeutic strategies in the management of patients with COVD-19. Harnessing the expertise of the biomedical and clinical communities is imperative to expand the available therapeutics beyond anticoagulants and to target both thrombocytopathy and endotheliopathy. Only with such collaborative efforts can we better prepare for further waves and for future coronavirus-related pandemics.
Conflict of interest statement
The authors declare no competing interests.
Figures
![Fig. 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7675396/bin/41569_2020_469_Fig1_HTML.gif)
![Fig. 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7675396/bin/41569_2020_469_Fig2_HTML.gif)
![Fig. 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7675396/bin/41569_2020_469_Fig3_HTML.gif)
![Fig. 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7675396/bin/41569_2020_469_Fig4_HTML.gif)
Similar articles
-
Thromboinflammation in COVID-19 acute lung injury.Paediatr Respir Rev. 2020 Sep;35:20-24. doi: 10.1016/j.prrv.2020.06.004. Epub 2020 Jun 11. Paediatr Respir Rev. 2020. PMID: 32653469 Free PMC article. Review.
-
Thrombotic Complications of COVID-19 Infection: A Review.Cardiol Rev. 2021 Jan/Feb;29(1):43-47. doi: 10.1097/CRD.0000000000000347. Cardiol Rev. 2021. PMID: 32947478 Review.
-
The Cross-Talk between Thrombosis and Inflammatory Storm in Acute and Long-COVID-19: Therapeutic Targets and Clinical Cases.Viruses. 2021 Sep 23;13(10):1904. doi: 10.3390/v13101904. Viruses. 2021. PMID: 34696334 Free PMC article.
-
The coagulopathy, endotheliopathy, and vasculitis of COVID-19.Inflamm Res. 2020 Dec;69(12):1181-1189. doi: 10.1007/s00011-020-01401-6. Epub 2020 Sep 12. Inflamm Res. 2020. PMID: 32918567 Free PMC article. Review.
-
SARS-CoV-2: What is known and what there is to know-Focus on coagulation and lipids.Eur J Clin Invest. 2020 Jul;50(7):e13311. doi: 10.1111/eci.13311. Epub 2020 Jun 25. Eur J Clin Invest. 2020. PMID: 32511751 Free PMC article. No abstract available.
Cited by
-
Practical approach to thrombocytopenia in patients with sepsis: a narrative review.Thromb J. 2024 Jul 22;22(1):67. doi: 10.1186/s12959-024-00637-0. Thromb J. 2024. PMID: 39039520 Free PMC article. Review.
-
Nonlinear relationship between platelet count and 30-day in-hospital mortality in ICU acute respiratory failure patients: a multicenter retrospective cohort study.Eur J Med Res. 2024 Jun 8;29(1):312. doi: 10.1186/s40001-024-01909-1. Eur J Med Res. 2024. PMID: 38849948 Free PMC article.
-
Blood perfusion with polymyxin B immobilized columns in patients with COVID-19 requiring oxygen therapy.Sci Rep. 2024 May 31;14(1):12550. doi: 10.1038/s41598-024-63330-2. Sci Rep. 2024. PMID: 38822071 Free PMC article.
-
In Silico Analyses Indicate a Lower Potency for Dimerization of TLR4/MD-2 as the Reason for the Lower Pathogenicity of Omicron Compared to Wild-Type Virus and Earlier SARS-CoV-2 Variants.Int J Mol Sci. 2024 May 17;25(10):5451. doi: 10.3390/ijms25105451. Int J Mol Sci. 2024. PMID: 38791489 Free PMC article.
-
Patterns of Multiple Organ Dysfunction and Renal Recovery in Critically Ill Children and Young Adults Receiving Continuous Renal Replacement Therapy.Crit Care Explor. 2024 May 6;6(5):e1084. doi: 10.1097/CCE.0000000000001084. eCollection 2024 May 1. Crit Care Explor. 2024. PMID: 38709083 Free PMC article.
References
-
- Johns Hopkins Coronavirus Resource Center. COVID-19 Dashboard. https://coronavirus.jhu.edu/map.html (2020).
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
- R01 HL115247/HL/NHLBI NIH HHS/United States
- R01 CA222518/CA/NCI NIH HHS/United States
- UL1 TR001863/TR/NCATS NIH HHS/United States
- R01 HL119529/HL/NHLBI NIH HHS/United States
- R01 HL146101/HL/NHLBI NIH HHS/United States
- R01 HL142090/HL/NHLBI NIH HHS/United States
- T32 HL007974/HL/NHLBI NIH HHS/United States
- R01 HL142818/HL/NHLBI NIH HHS/United States
- R01 DK102792/DK/NIDDK NIH HHS/United States
- U54 DK106857/DK/NIDDK NIH HHS/United States
- R01 HL151222/HL/NHLBI NIH HHS/United States
- R01 HL150515/HL/NHLBI NIH HHS/United States
- R01 HL122815/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous